Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir for HHV-8 Associated Multicentric Castleman's Disease
NCT00361933Phase 4Withdrawn
- Sponsor
- University of Washington
- Start
- Dec 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of valganciclovir in Multicentric Castleman disease (MCD), sponsored by University of Washington. Planned start Dec 2008; status: withdrawn.
02
Drugs
valganciclovir
03
Conditions
Multicentric Castleman disease (MCD)
Beyond the preview
Go deeper on NCT00361933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00361933.